Synopsis
Synopsis
0
KDMF
0
VMF
0
API
0
FDF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Amide, Procaine
2. Apo-procainamide
3. Biocoryl
4. Hydrochloride, Procainamide
5. Novocainamide
6. Novocamid
7. Procainamide
8. Procaine Amide
9. Procamide
10. Procan
11. Procan Sr
12. Procanbid
13. Pronestyl
14. Rhythmin
1. 614-39-1
2. Procainamide Hcl
3. Pronestyl
4. Procanbid
5. Procapan
6. Procan
7. Procan Sr
8. 4-amino-n-[2-(diethylamino)ethyl]benzamide Hydrochloride
9. Procainamide (hydrochloride)
10. Pronestyl-sr
11. Amidoprocaine
12. Cardiorytmin
13. Benzamide, 4-amino-n-[2-(diethylamino)ethyl]-, Monohydrochloride
14. 4-amino-n-[2-(diethylamino)ethyl]benzamide;hydrochloride
15. Nsc-757279
16. Mls000069436
17. Chebi:8429
18. Si4064o0lx
19. Benzamide, 4-amino-n-(2-(diethylamino)ethyl)-, Monohydrochloride
20. Smr000059079
21. Procainhydrochlorid
22. Procainii Chloridum
23. Promide Hydrochloride
24. Procapan Hydrochloride
25. Novocamid Hydrochloride
26. Procamide Hydrochloride
27. Procardyl Hydrochloride
28. 4-amino-n-(2-(diethylamino)ethyl)benzamide Hydrochloride
29. Procan-sr Hydrochloride
30. Procaine Amide Hydrochloride
31. Supicane Amide Hydrochloride
32. Procainamidehydrochloride
33. Ccris 7143
34. 4-amino-n-(2-diethylaminoethyl)benzamide Hydrochloride
35. Sr-01000000022
36. Cas-614-39-1
37. Einecs 210-381-7
38. Mfcd00012998
39. 7699-39-0
40. Unii-si4064o0lx
41. Procanbid (tn)
42. Pronestyl (tn)
43. Procainamide Hydrochloride [usp:jan]
44. Procan Sr (tn)
45. 4-aminobenzoesaeure-2-diethylaminoethylester Hydrochlorid
46. P-amino-n-(2-(diethylamino)ethyl)benzamide Hydrochloride
47. Pronestyl Hydrochloride
48. 4-amino-n-(2-(diethylamino)ethyl)benzamide Monohydrochloride
49. P-amino-n-(2-(diethylamino)ethyl)benzamide Monohydrochloride
50. Opera_id_1543
51. Procainamidi Hydrochloridum
52. Chembl605
53. Epitope Id:140114
54. Dsstox_cid_29382
55. Dsstox_rid_83497
56. Dsstox_gsid_49422
57. Schembl40758
58. Mls001148635
59. Spectrum1500503
60. Dtxsid2049422
61. Benzamide, P-amino-n-(2-(diethylamino)ethyl)-, Hydrochloride
62. Hms1569c15
63. Hms1920l04
64. Pharmakon1600-01500503
65. Act08464
66. Amy22225
67. Bcp28404
68. Hy-a0084
69. Tox21_202855
70. Tox21_500995
71. Ccg-39233
72. Nsc757279
73. S4294
74. Akos008056264
75. Ac-7552
76. Ks-5258
77. Lp00995
78. Nc00535
79. Nsc 757279
80. Procainamide Hydrochloride (jp17/usp)
81. Procainamide Hydrochloride [mi]
82. Procainamide Hydrochloride [jan]
83. Ncgc00094291-01
84. Ncgc00094291-02
85. Ncgc00094291-03
86. Ncgc00094291-04
87. Ncgc00094291-05
88. Ncgc00260401-01
89. Ncgc00261680-01
90. Procainamide Hydrochloride [mart.]
91. Procainamide Hydrochloride [vandf]
92. Procainamide Hydrochloride [usp-rs]
93. Procainamide Hydrochloride [who-dd]
94. Procainamide Hydrochloride [who-ip]
95. Db-053889
96. Procainamide Hydrochloride, >=98% (hplc)
97. Eu-0100995
98. Ft-0603493
99. Sw196878-3
100. Vu0239777-5
101. A14240
102. Bim-0050968.0001
103. D00477
104. D97622
105. P 9391
106. Procainamide Hydrochloride [orange Book]
107. 4-amino-n-(2-diethylamino-ethyl)-benzamide Hcl
108. Procainamide Hydrochloride [ep Monograph]
109. Procainamide Hydrochloride [usp Monograph]
110. Procainamidi Hydrochloridum [who-ip Latin]
111. Procainamide Hydrochloride, Purum, >=98.0% (at)
112. Sr-01000000022-2
113. Sr-01000000022-6
114. W-105155
115. Procainamide Hydrochloride 100 Microg/ml In Methanol
116. Q27108080
117. F0850-6742
118. 4-amino-n-[2'-(diethylamino)ethyl]benzamide Hydrochloride
119. 4-amino-n-[2-(diethylamino)ethyl]-benzamide Hydrochloride
120. P-amino-n-(2-(diethylamino)ethy)benzamide Monohydrochloride
121. Benzamide, 4-amino-n-(2-(diethylamino)ethyl)-, Hydrochloride (1:1)
122. Procainamide Hydrochloride, European Pharmacopoeia (ep) Reference Standard
123. 4-amino-n-(2-(diethylamino)ethyl)benzamide Monohydrochloride [who-ip]
124. Procainamide Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
125. Procainamide Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 271.78 g/mol |
---|---|
Molecular Formula | C13H22ClN3O |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 6 |
Exact Mass | 271.1451400 g/mol |
Monoisotopic Mass | 271.1451400 g/mol |
Topological Polar Surface Area | 58.4 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 221 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Procainamide hydrochloride |
Drug Label | Procainamide Hydrochloride Injection, USP is a sterile, nonpyrogenic solution of procainamide hydrochloride in water for injection. Each milliliter of the 2 mL vial contains procainamide hydrochloride 500 mg; methylparaben 1 mg and sodium metabisulfi... |
Active Ingredient | Procainamide hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 500mg/ml; 100mg/ml |
Market Status | Prescription |
Company | Hospira |
2 of 2 | |
---|---|
Drug Name | Procainamide hydrochloride |
Drug Label | Procainamide Hydrochloride Injection, USP is a sterile, nonpyrogenic solution of procainamide hydrochloride in water for injection. Each milliliter of the 2 mL vial contains procainamide hydrochloride 500 mg; methylparaben 1 mg and sodium metabisulfi... |
Active Ingredient | Procainamide hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 500mg/ml; 100mg/ml |
Market Status | Prescription |
Company | Hospira |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Voltage-Gated Sodium Channel Blockers
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)
Related Excipient Companies
Excipients by Applications
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?